March 20, 2018 / 12:19 PM / 9 months ago

BUZZ-Cardiome Pharma: Soars as Cipher agrees to buy Canadian business

** U.S.-listed shares of Cardiome Pharma rise 49.7 pct to $2.35 premarket; stock top percentage gainer

** Cipher Pharmaceuticals Inc to buy Cardiome’s Canadian business for C$25.5 mln ($19.53 mln), which will be financed through a combination of cash and debt

** CRME’s gains set to wipe out losses from August when U.S. FDA declined to accept re-submission of a marketing application for CRME’s heart drug, sending shares to a nine-month low

** Up to Monday’s close, CRME stock has lost about 50 pct over the past year ($1 = 1.3060 Canadian dollars) (Reporting by Tamara Mathias in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below